SCHEMBL30656341

SCHEMBL30656341

Oc1ccc2sccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.50
DYRK1A Q13627 3/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
PTPRC P08575 1/20 0.44
PTPN6 P29350 1/20 0.44
PTPN11 Q06124 1/20 0.44
PTPN22 Q9Y2R2 1/20 0.44
CTNNB1 P35222 1/20 0.43
WNT3A P56704 1/20 0.43
CLK1 P49759 2/20 0.41
DYRK1B Q9Y463 2/20 0.41
CYP1A2 P05177 1/20 0.41
CA2 P00918 3/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
CA12 O43570 2/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL534539 1.00 CYP2A6 (0.50) CYP2A6DYRK1ASLC6A2SLC6A4SLC6A3
SCHEMBL15537714 0.83 DYRK1A (0.58) CYP2A6DYRK1ACA2ESR1ESR2
SCHEMBL29766115 0.81 ESR1 (0.44) CYP2A6SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL911044 0.81 ESR1 (0.44) CYP2A6SLC6A2SLC6A4SLC6A3CYP1A2
SCHEMBL164774 0.73 CYP2A6 (0.50) CYP2A6DYRK1APTPRCPTPN6PTPN11
SCHEMBL3480312 0.73 CYP2A6 (0.42) CYP2A6DYRK1ASLC6A2SLC6A4SLC6A3
SCHEMBL17010916 0.73 CYP2A6 (0.52) CYP2A6DYRK1APTPRCPTPN6PTPN11
SCHEMBL18725846 0.71 CYP2A6 (0.50) CYP2A6DYRK1APTPRCPTPN6PTPN11
SCHEMBL2011544 0.71 CYP2A6 (0.50) CYP2A6DYRK1APTPRCPTPN6PTPN11
SCHEMBL155613 0.71 CYP2A6 (0.50) CYP2A6DYRK1ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
CN-119421879-A Novel derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-02-11 CN disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed